Leading High-Quality Specialized Respiratory Disease Care
through the Integration of Biosensing and AI

Ultra-Precision Sensing Technology

High-Sensitivity Detection

Reduces Cross-Infection Risk

Event showcase

Meet us at ERS 2026 September 5–9, 2026

Breath Gas Test System

Model BA200

Breath Gas Test System
View more

Impulse Oscillometry System (IOS)

Model IOS500

Impulse Oscillometry System (IOS)
View more

Breath Gas Test System

Model BA800

Breath Gas Test System
View more

Breath Gas Test System

Model BA200

Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.

More

Impulse Oscillometry System (IOS)

Model IOS500

Impulse Oscillometry System (IOS)
View more

Breath Gas Test System

Model BA800

Breath Gas Test System
View more

Global Presence

Company culture background

Who We Are

MISSION

Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.

PRODUCT FOCUS

Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases

VISION

Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.

News background

News, Events and Highlights

Chronic Airway Diseases: When Breathing Becomes a Long-Term Challenge—and How Doctors Tell Them Apart
November 20, 2026 News

Chronic Airway Diseases: When Breathing Becomes a Long-Term Challenge—and How Doctors Tell Them Apart

Chronic airway diseases—asthma, COPD, and bronchiectasis—are among the most common and burdensome respiratory conditions worldwide. They share overlapping symptoms such as cough, breathlessness, and sputum production, yet differ in unde...

FeNO and CaNO in Respiratory Medicine: From a “Composite Signal” to “Compartment-Specific Inflammation”
November 20, 2026 News

FeNO and CaNO in Respiratory Medicine: From a “Composite Signal” to “Compartment-Specific Inflammation”

FeNO and CaNO provide complementary rather than interchangeable information. FeNO is a composite signal reflecting predominantly central airway type 2 inflammation; it is measured at a single flow rate, is widely standardized, and has mat...

World COPD Day 2026: Why “Early” Is the Most Important Word in Lung Health
November 17, 2026 News

World COPD Day 2026: Why “Early” Is the Most Important Word in Lung Health

November 18, 2026 marks the 25th World COPD Day. This year’s theme, led by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is “Early Diagnosis and Management for a Better Life.” The message is delibera...

Global cooperation

Advancing Precision in Respiratory Care

Please complete the form to contact our team